Everything drug pricing and policy, every day
And companies with new meds are (again) getting shy about revealing prices at approval
Plus 84 pages on what the Democrats will do on healthcare if they retake the House
Plus more data on the link -- or lack thereof -- between 340B revenue and charity care
And a deep dive on 340B hospital financial assistance policies
And Chris Klomp’s ducked MFN and TrumpRx questions from Senators; his nomination advances anyway
And pressure on Europe -- especially Germany -- to raise drug prices intensifies
And South Dakota stopped a bounty program for racoon tails last year. That move saved more money than its new Medicaid MFN deal
